Determining the Success of a Urine Metabolite Point-of-care Colorectal Cancer Early Diagnosis Test in Africa
Determining the Success of a Urine Metabolite Point-of-care Colorectal Cancer Early Diagnosis Test in Africa
The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Inclusion Criteria:
Patient presents with one of the following:
Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-
Patients who present for a screening colonoscopy -OR-
Has received one of the following within 3 weeks of the planned urine collection
Age ≥ 18
Willingness to participate in the study
kinghamP@mskcc.org212-639-5260
iasonosa@mskcc.org646-227-3557
New York, New York 10065, United States
212-639-5260
Johannesburg, South Africa
abediako-bowan@ug.edu.gh
011 7263390/1
alex.mremi@kcmcu.ac.tz+255 717 083 983